Pfeffer U, Fecarotta E, Castagnetta L, Vidali G
Istituto Nazionale per la Ricerca sul Cancro, Laboratory of Molecular Biology, Genova, Italy.
Cancer Res. 1993 Feb 15;53(4):741-3.
We have identified a messenger RNA coding for a variant estrogen receptor jointly expressed with the normal mRNA in the estrogen receptor-positive, -responsive mammary carcinoma cell lines MCF-7 and ZR 75-1 by means of reverse transcription polymerase chain reaction. This variant mRNA was not observed in estrogen receptor-negative, -unresponsive MDA-MB 231 cells. Partial sequence analysis of the variant complementary DNA revealed identity to sequences of the estrogen receptor exons 3, 5, and 6, but the absence of the entire exon 4. We suggest that this variant receptor messenger is created by alternative splicing. The variant protein is expected to lack most of the hinge domain and part of the hormone binding domain, and it might have a cellular distribution and estrogen-binding affinity different from that of the normal receptor protein.
我们通过逆转录聚合酶链反应,在雌激素受体阳性且有反应的乳腺癌细胞系MCF-7和ZR 75-1中,鉴定出一种编码变体雌激素受体的信使核糖核酸,它与正常信使核糖核酸共同表达。在雌激素受体阴性且无反应的MDA-MB 231细胞中未观察到这种变体信使核糖核酸。对变体互补脱氧核糖核酸的部分序列分析显示,它与雌激素受体外显子3、5和6的序列相同,但缺少整个外显子4。我们认为这种变体受体信使是通过可变剪接产生的。预计该变体蛋白将缺乏大部分铰链区和部分激素结合区,并且其细胞分布和雌激素结合亲和力可能与正常受体蛋白不同。